404K+ Certified
6M+ people recommended
Fully accredited courses
Health and Social Care
Medication Training
Updated: 25 Jul 2026

Syringe Driver Awareness

£29.99 + VAT
Add
Accreditations
Updated:
25 Jul 2026
24587 People
Recommended
Duration
Minimum 120 mins
100% Online
Course
365 Days
Access
Instant Access and
Certification
Full
Voiceover

Syringe Driver Awareness course provides essential guidance on safe use, monitoring, documentation and reporting concerns when supporting individuals receiving continuous subcutaneous medication.

£29.99 + VAT
Add
Accreditations

Learning Outcomes.

By the end of this course,
participants will be able:

To understand the principles of palliative and end of life care and the role of syringe drivers in supporting symptom management, comfort and person-centred care.

To recognise the indications, benefits, limitations and safe use of continuous subcutaneous infusion in accordance with current UK guidance and evidence-based practice.

To understand medicines management principles, including commonly used medicines, drug compatibility, safe administration, documentation and controlled drug responsibilities.

To identify appropriate infusion sites, monitor syringe drivers safely, recognise common complications and apply infection prevention and risk reduction measures.

To understand professional, legal and ethical responsibilities relating to consent, mental capacity, communication, governance and multidisciplinary working in syringe driver care.

To promote safe practice, reflective learning and continuing professional development in order to maintain competence, patient safety and high-quality end of life care.

Course
Contents.

01
Palliative and End of Life Care Principles

Explores the aims of palliative and end of life care, including comfort, dignity, symptom control and person-centred support for patients with progressive or life-limiting conditions.

03
Recognising When a Syringe Driver May Be Required

Identifies clinical situations in which oral or other routes of medicine administration may be unsuitable, unreliable or poorly tolerated.

05
Professional, Legal and Medicines Management Responsibilities

Examines professional accountability, scope of practice, organisational policies, medicines legislation and the responsibilities of healthcare professionals involved in syringe driver care.

08
Infusion Site Selection, Monitoring and Routine Checks

Covers the selection and assessment of appropriate subcutaneous sites, ongoing monitoring and routine checks of the device, infusion line, prescription and patient response.

06
Medicines, Compatibility and Stability

Introduces medicines commonly administered through syringe drivers and explains the principles of compatibility, dilution, concentration, stability and safe medicine combinations.

09
Troubleshooting, Complications and Infection Prevention

Explains how to recognise common device, site and medicine-related problems, manage complications, maintain infection prevention standards and escalate concerns appropriately.

02
Purpose and Function of Syringe Drivers

Explains what a syringe driver is and how continuous subcutaneous infusion can deliver medicines at a controlled rate over a specified period.

04
Benefits, Limitations and Patient Communication

Reviews the advantages and limitations of syringe driver use and outlines the importance of clear, sensitive communication with patients, families and carers.

07
Equipment, Documentation and Safe Administration

Describes the equipment used for continuous subcutaneous infusion and the documentation, checking and medicines safety processes required to support safe practice.

10
Governance, Ethics and Professional Development

Addresses professional standards, consent, mental capacity, ethical decision-making, multidisciplinary communication, reflective practice, learning from incidents and continuing professional development.

Syringe Driver Awareness course provides essential guidance on safe use, monitoring, documentation and reporting concerns when supporting individuals receiving continuous subcutaneous medication.

Summary